Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
mRNA | SPINT1 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-08 |
mRNA | P2RY2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
mRNA | CCDC172 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
mRNA | SH3TC2 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-08 |
mRNA | GJB3 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
mRNA | TREM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | AMPD2 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
mRNA | KLC3 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | TGFA | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |